These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15269878)

  • 1. Patient management decisions in chronic lymphocytic leukemia: an introduction and an editorial.
    Binet JL
    Semin Hematol; 2004 Jul; 41(3):191. PubMed ID: 15269878
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in chronic lymphocytic leukemia.
    Vyas N; Hassan A
    Indian J Cancer; 2012; 49(1):137-43. PubMed ID: 22842181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgVH mutations in patients with chronic lymphocytic leukemia.
    Foà R
    Haematologica; 2005 Apr; 90(4):434-5. PubMed ID: 15820928
    [No Abstract]   [Full Text] [Related]  

  • 4. [Impact of immunoglobulin gene somatic high mutation on prognosis of the chronic lymphocytic leukemia].
    Liu H; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1588-91. PubMed ID: 20030953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational status of IgV(H) genes in B-cell chronic lymphocytic leukemia and prognosis: percent mutations or antigen-driven selection?
    Bomben R; Dal Bo M; Zucchetto A; Zaina E; Nanni P; Sonego P; Del Poeta G; Degan M; Gattei V
    Leukemia; 2005 Aug; 19(8):1490-2. PubMed ID: 15944717
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of telomere length on the outcome of allogeneic stem cell transplantation for poor-risk chronic lymphocytic leukaemia: results from the GCLLSG CLL3X trial.
    Scheffold A; Jebaraj BMC; Jaramillo S; Tausch E; Steinbrecher D; Hahn M; Böttcher S; Ritgen M; Bunjes D; Zeis M; Stadler M; Uharek L; Scheid C; Hegenbart U; Hallek M; Kneba M; Schmitz N; Döhner H; Dreger P; Stilgenbauer S
    Br J Haematol; 2017 Oct; 179(2):342-346. PubMed ID: 27391907
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoglobulin heavy chain variable region gene repertoire and B-cell receptor stereotypes in Indian patients with chronic lymphocytic leukemia.
    Rani L; Mathur N; Gogia A; Vishnubhatla S; Kumar L; Sharma A; Dube D; Kaur P; Gupta R
    Leuk Lymphoma; 2016 Oct; 57(10):2389-400. PubMed ID: 26942309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia.
    Bosch F; Muntañola A; Giné E; Carrió A; Villamor N; Moreno C; Crespo M; Montserrat E
    Cytometry B Clin Cytom; 2006 Jul; 70(4):214-7. PubMed ID: 16906580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia.
    Rodríguez CM; Stanganelli C; Bussi C; Arroyo D; Sastre D; Heller V; Iribarren P; Slavutsky I
    Leuk Lymphoma; 2018 May; 59(5):1239-1243. PubMed ID: 28868956
    [No Abstract]   [Full Text] [Related]  

  • 10. Inactivation of p53 and deletion of ATM in B-CLL patients in relation to IgVH mutation status and previous treatment.
    Trbusek M; Malcikova J; Smardova J; Kuhrova V; Mentzlova D; Francova H; Bukovska S; Svitakova M; Kuglik P; Linkova V; Doubek M; Brychtova Y; Zacal J; Kujickova J; Pospisilova S; Dvorakova D; Vorlicek J; Mayer J
    Leukemia; 2006 Jun; 20(6):1159-61. PubMed ID: 16572201
    [No Abstract]   [Full Text] [Related]  

  • 11. Initiation of Treatment in Chronic Lymphocytic Leukemia.
    Pagel JM
    Clin Adv Hematol Oncol; 2016 May; 14(5 Suppl 8):3-5. PubMed ID: 27168202
    [No Abstract]   [Full Text] [Related]  

  • 12. Classical and new prognostic factors in chronic lymphocytic leukemia: where to now?
    Montserrat E
    Hematol J; 2002; 3(1):7-9. PubMed ID: 11960388
    [No Abstract]   [Full Text] [Related]  

  • 13. Determining mutational status of immunoglobulin v genes in chronic lymphocytic leukemia: a useful prognostic indicator.
    Sahota SS; Babbage G; Zojer N; Ottensmeier CH; Stevenson FK
    Methods Mol Med; 2005; 115():129-44. PubMed ID: 15998966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tp53 gene p72R polymorphism in chronic lymphocytic leukemia: incidence and clinical significance amongst cases with unmutated immunoglobulin receptors.
    Gemenetzi K; Galigalidou C; Vlachonikola E; Stalika E; Xochelli A; Baliakas P; Karypidou M; Touloumenidou T; Minga E; Douka V; Iskas M; Athanasiadou A; Makris A; Stavroyianni N; Anagnostopoulos A; Hadzidimitriou A; Stamatopoulos K
    Leuk Lymphoma; 2017 Mar; 58(3):726-728. PubMed ID: 27686405
    [No Abstract]   [Full Text] [Related]  

  • 15. Determining the clinical course and outcome in chronic lymphocytic leukemia.
    Rai KR; Chiorazzi N
    N Engl J Med; 2003 May; 348(18):1797-9. PubMed ID: 12724486
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic lymphocytic leukemia: to transplant or not to transplant... that is the question?
    Nabhan C; Bitran JD
    J Clin Oncol; 2005 Nov; 23(31):8126-7; author reply 8127. PubMed ID: 16258116
    [No Abstract]   [Full Text] [Related]  

  • 17. MicroRNA in chronic lymphocytic leukemia.
    Chng WJ
    N Engl J Med; 2006 Feb; 354(5):524-5; author reply 524-5. PubMed ID: 16456940
    [No Abstract]   [Full Text] [Related]  

  • 18. Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment.
    Morabito F; Cutrona G; Mosca L; D'Anca M; Matis S; Gentile M; Vigna E; Colombo M; Recchia AG; Bossio S; De Stefano L; Maura F; Manzoni M; Ilariucci F; Consoli U; Vincelli I; Musolino C; Cortelezzi A; Molica S; Ferrarini M; Neri A
    Leuk Res; 2015 Aug; 39(8):840-5. PubMed ID: 26038121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?
    Bhoi S; Baliakas P; Cortese D; Mattsson M; Engvall M; Smedby KE; Juliusson G; Sutton LA; Mansouri L
    Haematologica; 2016 Feb; 101(2):e63-5. PubMed ID: 26589911
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases.
    Morabito F; Shanafelt TD; Gentile M; Reda G; Mauro FR; Rossi D; Di Renzo N; Molica S; Angrilli F; Chiarenza A; Cutrona G; Chaffee KG; Parikh SA; Tripepi G; D'Arrigo G; Vigna E; Recchia AG; Cortelezzi A; Gaidano G; Di Raimondo F; Fais F; Foà R; Neri A; Ferrarini M
    Am J Hematol; 2018 Sep; 93(9):E216-E219. PubMed ID: 29984867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.